Abstract
dc:description.abstractgeneralThe liver is the largest internal organ in the body. It is responsible for performing an array of vital functions, including the filtration of blood, synthesis of different molecules, and metabolism of drugs and toxicants. Hepatocytes, or the main liver cell type, perform most of these functions. Typically, primary human hepatocytes (PHHs) are ideal for in vitro liver studies since they are obtained directly from tissues and exhibit adult characteristics and functions. However, sourcing these adult liver cells is extremely difficult since they are usually obtained through biopsies and are limited in quantity. Induced pluripotent stem cell (iPSC)-hepatocyte-like cells (iHLCs) hold tremendous potential to be used as a substitute since they can be obtained non-invasively. However, iHLCs require further maturation before they can be substituted for PHHs due to their lower liver-related functions and immature characteristics. Existing maturation approaches require the administration of chemical mixtures that can be up to a million times higher than the concentrations of these same molecules inside the body. The lack of a systematic approach to mature iHLCs currently limits their widespread use. During liver development, neighboring cells secrete different proteins that regulate and induce multiple pathways that aid in the maturation of cells into adult liver cells. We report the assembly of a multicellular 3D human liver organoid with iHLCs that recapitulates the in vivo hepatic microenvironment. Intra- and intercellular signaling between human hepatic cells in the organoid result in mature iHLCs that exhibit several markers and functions of PHHs within one to two weeks in culture. When two other hepatic cell types, Kupffer cells and liver sinusoidal endothelial cells, are present in the organoids, they secrete signaling molecules that synergistically mature iHLCs. Relying solely on intercellular secretion from the cells provides a systematic and reproducible approach to generate mature iHLCs for drug, disease, and patient-specific in vitro studies.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy
- Level thesis:degree_level
- doctoral
- Discipline thesis:degree_discipline
- Chemical Engineering
- Department dc:contributor.department
- Chemical Engineering
- Grantor dc:publisher
- Virginia Tech
- Year dc:date.issued
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Gandhi, Neeti Nimish
- Chair dc:contributor.committeechair
-
- Rajagopalan, Padmavathy
- Committee members dc:contributor.committeemember
-
- Wrenn, Steven Parker
- Lee, Yong Woo
- Tong, Rong
- Davis, Richey M.
Subjects
dc:subject × 5Rights
dc:rights- Statement dc:rights
-
- In Copyright
- Licence dc:rights.uri
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Dc Identifier Other
- vt_gsexam:41770
- OAI identifier oai:identifier
- oai:vtechworks.lib.vt.edu:10919/123753